Professionals from Cayuga Health have joined their Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center counterparts to care for New Yorkers diagnosed with COVID-19.
Three collaborative New York City-based projects, designed to inspire cross-campus research partnerships, have been awarded grant funding totaling approximately $500,000 from the College of Agriculture and Life Sciences.
The temporary benefits of ketamine against depression might be extended if the new brain-cell connections it promotes could be preserved, according to a study by researchers at Weill Cornell Medicine.
A new AI approach by Weill Cornell Medicine investigators can accurately identify whether a 5-day-old, IVF human embryo has high potential to progress to a successful pregnancy.
Study describes for the first time how combinations of proteins combine to inhibit and sabotage the plant’s defenses, so a pathogen can infect its host.
With lives and livelihoods on pause due to COVID-19, Cornell’s Institute of Politics and Global Affairs hosted a TeleTown Hall April 8 to explore a potential timeline for treatment.
Clinical immunologist Dr. Helen Su, who studies the genetic causes of rare immune system diseases in children, has been awarded the Drukier Prize in Children’s Health Research by Weill Cornell Medicine.